189 related articles for article (PubMed ID: 38268853)
1. Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies.
Liao YL; Zhu GY; Chang C
Front Cardiovasc Med; 2023; 10():1291438. PubMed ID: 38268853
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
[TBL] [Abstract][Full Text] [Related]
5. Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang L; Sang B; Zheng Z
Front Aging Neurosci; 2022; 14():985109. PubMed ID: 36204558
[TBL] [Abstract][Full Text] [Related]
6. Smoking cessation for secondary prevention of cardiovascular disease.
Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
[TBL] [Abstract][Full Text] [Related]
7. The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis.
Prasad M; Gupta S; Sarin SK
J Clin Exp Hepatol; 2024; 14(1):101277. PubMed ID: 38076375
[TBL] [Abstract][Full Text] [Related]
8. Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis.
Abosheaishaa H; Hussein M; Ghallab M; Abdelhamid M; Balassiano N; Ahammed MR; Baig MA; Khan J; Elshair M; Soliman MY; Abdelwahed M; Ali A; Alzamzamy A; Nassar M
Diabetes Metab Syndr; 2024 Jan; 18(1):102938. PubMed ID: 38194827
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
[TBL] [Abstract][Full Text] [Related]
10. Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis.
Wang M; Zhou BG; Zhang Y; Ren XF; Li L; Li B; Ai YW
Front Cardiovasc Med; 2022; 9():812030. PubMed ID: 35345491
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis.
Shea S; Lionis C; Kite C; Lagojda L; Uthman OA; Dallaway A; Atkinson L; Chaggar SS; Randeva HS; Kyrou I
Front Endocrinol (Lausanne); 2024; 15():1357664. PubMed ID: 38689730
[TBL] [Abstract][Full Text] [Related]
13. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
[TBL] [Abstract][Full Text] [Related]
15. The effect of occupational exposure to noise on ischaemic heart disease, stroke and hypertension: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-Related Burden of Disease and Injury.
Teixeira LR; Pega F; Dzhambov AM; Bortkiewicz A; da Silva DTC; de Andrade CAF; Gadzicka E; Hadkhale K; Iavicoli S; Martínez-Silveira MS; Pawlaczyk-Łuszczyńska M; Rondinone BM; Siedlecka J; Valenti A; Gagliardi D
Environ Int; 2021 Sep; 154():106387. PubMed ID: 33612311
[TBL] [Abstract][Full Text] [Related]
16. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
Wu S; Wu F; Ding Y; Hou J; Bi J; Zhang Z
Sci Rep; 2016 Sep; 6():33386. PubMed ID: 27633274
[TBL] [Abstract][Full Text] [Related]
17. The Global Prevalence of Nonalcoholic Fatty Liver Disease and its Association With Cancers: Systematic Review and Meta-Analysis.
Muhamad NA; Maamor NH; Leman FN; Mohamad ZA; Bakon SK; Abdul Mutalip MH; Rosli IA; Aris T; Lai NM; Abu Hassan MR
Interact J Med Res; 2023 Jul; 12():e40653. PubMed ID: 37467012
[TBL] [Abstract][Full Text] [Related]
18. The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose-response meta-analysis.
Ling Q; Chen J; Liu X; Xu Y; Ma J; Yu P; Zheng K; Liu F; Luo J
Front Endocrinol (Lausanne); 2022; 13():1043169. PubMed ID: 36743937
[TBL] [Abstract][Full Text] [Related]
19. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
20. Association between metabolic dysfunction-associated steatotic liver disease and risk of incident pancreatic cancer: a systematic review and meta-analysis of cohort studies.
Zhang Y; Zhou BG; Zhan JD; Du BB
Front Oncol; 2024; 14():1366195. PubMed ID: 38567158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
